Search Results

CAR-T cells express synthetic receptors that detect specific molecular markers, or antigens, on cancer cells using an antibody fragment as an external sensor. (Unsplash)
Biotechnology

A Remote-Controlled Car for Cancer Immunotherapy

MBT Desk
4 min read
The researchers next plan to better characterize the performance of their iON and iONØ-CARs against different tumor models
Pembrolizumab significantly prolongs cancer-free time in high-risk bladder cancer patients, according to a large clinical trial. (Wikimedia Commons)
Medicine

Immunotherapy Drug Pembrolizumab Shows Doubling Cancer-Free Time for Bladder Cancer Patients

Ankur Deka
3 min read
A large clinical trial reveals that patients with high-risk muscle-invasive bladder cancer benefit significantly from pembrolizumab treatment
Immunotherapy has transformed melanoma treatment, with over half of advanced patients now surviving more than 10 years. (Wikimedia Commons)
Fitness and Wellness

Immunotherapy Breakthrough: Over Half of Advanced Melanoma Patients Now Survive Beyond 10 Years

Ankur Deka
3 min read
New research reveals that combining two immunotherapy drugs has significantly boosted long-term survival rates for advanced melanoma patients
Supercharging immune cells to battle blood cancer: breakthrough in cancer immunotherapy (Representational Image: Pixabay)
Medicine

Supercharging Immune Cells to Battle Blood Cancer: Breakthrough in Cancer Immunotherapy

MBT Desk
2 min read
Immune checkpoint therapy (ICT) has made remarkable strides in cancer treatment
The study tested mirvetuximab soravtansine and pembrolizumab in patients with folate receptor-α (FRα) positive recurrent microsatellite stable (MSS) / mismatch repair proficient (pMMR) serous endometrial cancer. (Representational Image: Unsplash)
Medicine

Novel ADC and Immunotherapy Combo Bring Hope in Endometrial Cancer Subtype

MBT Desk
3 min read
A novel combination of an antibody-drug conjugate and an immune checkpoint inhibitor showed notable activity in pre-treated patients with a difficult-to-treat form of endometrial cancer.
Alzheimer’s disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline. (Representational Image: Unsplash)
Medicine

Immunotherapy for Alzheimer’s Disease Shows Promise in Mouse Study

MBT Desk
4 min read
Alzheimer’s disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline.
Read More
logo
Medbound
www.medboundtimes.com